Tag Archives: (NYSE:NVS)

Novartis On Its Way To $100

Novartis (NYSE:NVS) announced its second quarter earnings report there this week and I don’t think there was anything in the announcement that should make long investors doubt their current position. Why? Well if we look at the fundamentals of the … Continue reading

Posted in Novartis | Tagged | Leave a comment

Novartis Should Be Bought On A Pullback

Novartis (NYSE:NVS) Should Be Bought On A Pullback. Entresto & Cosentyx drugs really have the ability to drive sales forward.

Posted in Novartis | Tagged | Leave a comment

Novartis Is Worth At Least $80-$85 A Share

In our portfolio as of late, we have refrained from selling option premium for a few reasons. Firstly after the French election over the weekend, the volatility index CBOE Volatility Index (INDEXCBOE:VIX) really contracted and actually collapsed by 27% on the … Continue reading

Posted in Novartis | Tagged | Leave a comment

Two Pharmaceutical Companies On Sale

Following on from our last post where we discussed having the “end goal in mind” before starting to invest, today we are going delve more into this topic by plucking out a few examples the market is giving to us … Continue reading

Posted in Recommendations | Tagged , | Leave a comment